Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by Talaromyces marneffei
Le T., Ly VT., Thu NTM., Nguyen A., Thanh NT., Chau NVV., Thwaites G., Perfect J., Kolamunnage-Dona R., Hope W.
Amphotericin B deoxycholate (DAmB) is a first-line agent for the initial treatment of talaromycosis. However, little is known about the population pharmacokinetics and pharmacodynamics of DAmB for talaromycosis.